GL1X · GenesisL1 explorer

MolNFT v1 · #132338 · protein

TGF-beta receptor type 1 kinase domain (T204D) in complex with 6-[4- (3-chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-1H-imidazol-5- YL]IMIDAZO[1,2-B]PYRIDAZINE-3-carbonitrile

5QU0 · TGF-beta receptor type-1: “TGF-beta receptor type 1 kinase domain (T204D) in complex with 6-[4…”. X-ray diffraction, 1 ligand (QMV), 2 pockets (best druggability 0.74). MolNFT v1 #132338 on GenesisL1: 3D structure, binding sites and…

PDB
5QU0
Type
protein
Length
306 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
TGF-beta receptor type-1
EC
2.7.11.30
UniProt
P36897
Ligands
QMV
Pockets
2 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATGF-beta receptor type-1 (EC 2.7.11.30)protein30640% helix, 21% strandP36897

Ligands and binding sites

  • QMV · 6-[4-(3-chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-1H-imidazol-5-yl]imidazo[1,2-b]pyridazine-3-carbonitrile · ligand · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1720.740.9821empty
23230.670.8243QMV

Compared structures

  • 5QU0 · TGF-beta receptor type 1 kinase domain (T204D) in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • P36897 · AlphaFold monomer V2.0 prediction for TGF-beta receptor type-1 (P36897) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.